版本:
中国

BRIEF-FDA grants fast track designation for Shire's Recombinant ADAMTS13

March 22 Shire Plc:

* Shire receives FDA fast track designation for Recombinant ADAMTS13 (SHP655) for treatment of hereditary thrombotic thrombocytopenic purpura Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐